Shalby Hospitals IPO

Shalby Limited IPO

Business description – Shalby Limited is one of the leading multi-specialty chain of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. As on the date of this Red Herring Prospectus, it provides inpatient and outpatient healthcare services through 11 operational hospitals with an aggregate bed capacity of 2,012 beds. As on 30 June 2017, the company had nine operational hospitals with an aggregate operational bed count of 841 beds. It had a 15% market share of all joint replacement surgeries conducted by private corporate hospitals in India in 2016. As on the date of this Red Herring Prospectus, the company also provides outpatient services through 47 Outpatient Clinics and has ten shared surgery centres within third party hospitals, which we call Shalby Arthroplasty Centre of Excellence (SACE), where it offers orthopaedic healthcare services including surgeries. Since March 2007, it has conducted an aggregate of 92,100 surgeries, and provided healthcare services to an aggregate of 1,025,533 patients, consisting 133,652 inpatients and 891,881 outpatients.

Headquartered in Ahmedabad, India, it has a domestic and overseas outreach through a network of hospitals in India, and Outpatient Clinics and SACE located in India, Africa, and the Middle East. Having strong presence in western and central India and focus on Tier – I and Tier – II cities, its hospitals operate across five states, Outpatient Clinics operate across 37 cities in 12 states in India, and SACE are present in seven cities in six states in India. Its international footprint consists five Outpatient Clinics and one SACE in Africa, and two SACE in the UAE. The company is expanding footprint in western and central India with hospitals being set up in Nashik and Vadodara.

Promoters of Shalby Hospitals – Dr Vikram Shah, Dr Darshini Shah, Shanay Shah, Zodiac Mediquip Limited and Shah Family Trust

Shalby Hospitals IPO details
Subscription Dates 5 – 7 December 2017
Price Band INR245 – 248 per share
Fresh issue INR480 crore
Offer For Sale 1,000,000 shares (INR24.5 – 24.8 crore)
Total IPO size INR504.5 – 504.8 crore
Minimum bid (lot size) 60 shares
Face Value  INR10 per share
Retail Allocation 35%
Listing On NSE, BSE
Shalby Limited’s financial performance (in INR crore)
FY2013 FY2014 FY2015 FY2016 FY2017 Q1 FY2018
Total revenue 229.8 261.7 277.6 292.6 332.9 90.6
Total expenses 211.1 209.5 234.6 256.6 279.6 72.0
Profit after tax 17.1 39.0 25.7 37.6 62.6 14.4

Shalby Limited 
Opp Karnawati Club, Sarkhej Gandhinagar Highway
Near Prahlad Nagar Garden
Ahmedabad – 380 015

Phone: +91 79 4020 3000
Fax: 
+91 79 4020 3120
Email:
[email protected]
Website: www.shalby.org

Karvy Computershare Private Limited
Karvy Selenium Tower B, Plot 31-32,
Gachibowli, Nanakramguda,
Hyderabad – 500 032, Telangana

Phone: +91 40 6716 2222 
Fax:
 +91 40 2343 1551 
Email:
 [email protected]
Website: www.karvycomputershare.com

Earnings Per Share (EPS): INR7.16

Price/Earnings (P/E) ratio: 34.22 – 34.63

Return on Net Worth (RONW): 23.54%

Net Asset Value (NAV): INR30.40 per share

Shalby Hospitals IPO Subscription Details

Category Shares offered Subscription (no. of times, at 5PM)
Day 1 Day 2 Day 3
QIB 4,165,267 0.33 0.33 2.33
NII 3,070,626 0.01 0.01 0.42
Retail 7,164,793 0.20 0.70 2.73
Employees 121,000 0.23 0.61 1.41
Total 14,521,686 0.20 0.45 2.69

Shalby Hospitals IPO allotment status is now available on Karvy Computershare’s website. Click on this link to get allotment status.

IPO Opening Date: 5 December 2017

IPO Closing Date: 7 December 2017

Finalisation of Basis of Allotment: 12 December 2017

Initiation of refunds: 13 December 2017

Transfer of shares to demat accounts: 14 December 2017

Listing Date: 15 December 2017

Listing Price on NSE: INR239.7 per share (down 3.34% from IPO price)

Closing Price on NSE: INR239.6 per share (down 3.39% from IPO price)

100 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here